secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2024-10-31T23:59:59+00:00
Accession:  0001493152-24-043134
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mangoceuticals regains Nasdaq minimum bid price compliance after reverse stock split
--------------------------------------------------------------------------------

- Received Nasdaq letter on Oct 30, 2024 confirming full compliance with Minimum Bid Price Requirement.
- 1-for-15 reverse stock split effective Oct 16, 2024 helped meet the $1.00 bid price threshold.
- Nasdaq determined closing bid price was at or above $1.00 for 10 consecutive business days.
- Compliance matter is now closed, removing delisting risk from Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315224043134/0001493152-24-043134-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315224043134/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-043134

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer